In the context of SLE, TPO-RAs warrant particular caution because a subset of patients have coexisting antiphospholipid antibodies or established antiphospholipid syndrome, both of which increase thrombotic risk [32,33]. This evidence concerns the gene TPO and systemic lupus erythematosus.